Provided by Tiger Trade Technology Pte. Ltd.

PROCEPT BioRobotics

21.68
+0.95004.58%
Post-market: 22.170.4874+2.25%19:30 EDT
Volume:821.95K
Turnover:17.79M
Market Cap:1.24B
PE:-11.13
High:22.00
Open:20.77
Low:20.77
Close:20.73
52wk High:42.43
52wk Low:16.67
Shares:57.27M
Float Shares:54.47M
Volume Ratio:0.91
T/O Rate:1.51%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9478
EPS(LYR):-1.7207
ROE:-30.24%
ROA:-14.39%
PB:3.65
PE(LYR):-12.60

Loading ...

Baird Initiates PROCEPT BioRobotics at Neutral With $30 Price Target

MT Newswires Live
·
Mar 06

Procept BioRobotics names Daniel Puckett to board and audit committee

Reuters
·
Mar 06

PROCEPT BioRobotics Initiated at Neutral by Baird

Dow Jones
·
Mar 06

Procept BioRobotics initiated with a Neutral at Baird

TIPRANKS
·
Mar 06

Levi & Korsinsky Launches Fraud Probe Into Procept BioRobotics

Reuters
·
Mar 04

Stock Track | PROCEPT BioRobotics Plunges 9.39% in After-Hours Trading Following Multiple Analyst Price Target Cuts

Stock Track
·
Mar 03

Procept BioRobotics price target lowered to $30 from $62 at UBS

TIPRANKS
·
Mar 02

PROCEPT BioRobotics Is Maintained at Buy by Truist Securities

Dow Jones
·
Mar 02

Truist Adjusts Price Target on PROCEPT BioRobotics to $30 From $47, Maintains Buy Rating

MT Newswires Live
·
Mar 02

PROCEPT BioRobotics (PRCT) Gets a Buy from Truist Financial

TIPRANKS
·
Mar 02

PROCEPT BioRobotics (PRCT) Is Down 16.8% After Cutting 2026 Outlook And Widening Q4 Losses

Simply Wall St.
·
Mar 02

Stock Track | PROCEPT BioRobotics Plunges 6.90% After Q4 Revenue Miss, Broker Downgrades and Fraud Probe

Stock Track
·
Feb 27

Ademi LLP Probes Possible Securities Fraud at Procept BioRobotics

Reuters
·
Feb 27

Procept Biorobotics Publishes Investor Day Presentation on Aquablation Growth and Profitability Strategy

Reuters
·
Feb 27

PROCEPT BioRobotics Is Maintained at Overweight by Piper Sandler

Dow Jones
·
Feb 27

PROCEPT BioRobotics Down Over 22%, on Track for Lowest Close Since February 2022 -- Data Talk

Dow Jones
·
Feb 27

Procept Biorobotics Shares Slump 23.9% After Q4 Revenue Miss, Multiple Brokerages Cut PT

THOMSON REUTERS
·
Feb 27

Oppenheimer Downgrades PROCEPT BioRobotics to Perform From Outperform, Removes $60 Price Target

MT Newswires Live
·
Feb 26

Procept Biorobotics : Oppenheimer Cuts to Perform From Outperform

THOMSON REUTERS
·
Feb 26

Top Premarket Decliners

MT Newswires Live
·
Feb 26